Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LANREOTIDE for Carcinoid tumour of the small bowel: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 298 adverse event reports in the FDA FAERS database where LANREOTIDE was used for Carcinoid tumour of the small bowel.

Most Reported Side Effects for LANREOTIDE

Side Effect Reports % Deaths Hosp.
Diarrhoea 1,646 18.3% 66 418
Off label use 1,536 17.1% 277 470
Death 1,177 13.1% 1,177 215
Fatigue 1,022 11.4% 44 307
Nausea 775 8.6% 36 252
Abdominal pain 662 7.4% 70 288
Injection site pain 618 6.9% 21 105
Malaise 520 5.8% 44 222
Headache 515 5.7% 11 126
Asthenia 483 5.4% 67 218
Vomiting 468 5.2% 46 258
Pain 451 5.0% 35 179
Dizziness 441 4.9% 12 144
Weight decreased 430 4.8% 43 208
Injection site mass 400 4.4% 12 72

Other Indications for LANREOTIDE

Neuroendocrine tumour (2,629) Acromegaly (1,956) Product used for unknown indication (1,419) Gastroenteropancreatic neuroendocrine tumour disease (586) Carcinoid syndrome (581) Carcinoid tumour (496) Off label use (429) Pancreatic neuroendocrine tumour (232) Gigantism (112) Pancreatic carcinoma (85)

Other Drugs Used for Carcinoid tumour of the small bowel

TELOTRISTAT ETHYL (488) OCTREOTIDE (99) EVEROLIMUS (31) LUTETIUM OXODOTREOTIDE LU-177 (18) CAPECITABINE (12)

Related Pages

LANREOTIDE Full Profile All Carcinoid tumour of the small bowel Drugs LANREOTIDE Demographics LANREOTIDE Timeline